Finance

Lists
Why is FBIO up ७.९७%?
Dive Deeper
FBIO:NASDAQ
Fortress Biotech Inc
US$ १.९६
+७.९७%
(+०.१४) 1D
नोभेम्बर १८, १५:२५:०४ GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for FBIO...
Open
US$ १.८०
High
US$ १.९६
Low
US$ १.८०
Mkt. cap
६.६३ करोड
Avg. vol.
२.३५ लाख
Volume
२.८० लाख
P/E ratio
०.७४
52-wk high
US$ ४.५३
52-wk low
US$ १.६४
EPS
US$ २.६५
Beta
१.२७
Shares outstanding
३.३४ करोड
No. of employees
७८
Open
US$ १.८०
High
US$ १.९६
Low
US$ १.८०
Mkt. cap
६.६३ करोड
Avg. vol.
२.३५ लाख
Volume
२.८० लाख
P/E ratio
०.७४
52-wk high
US$ ४.५३
52-wk low
US$ १.६४
EPS
US$ २.६५
Beta
१.२७
Shares outstanding
३.३४ करोड
No. of employees
७८
News stories
From web sources and news partners
Profile
Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida. Wikipedia
About Fortress Biotech Inc
CEOLindsay Rosenwald
Employees७८
Founded२००६
HeadquartersBay Harbor Islands, फ्लोरिडा, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Analyst ratings
Based on 2 analysts giving stock ratings to FBIO in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for FBIO in the last 3 months.
Highest
Current US$ १.९६
US$ १७.०० (+७६५.१४%)
Average
US$ ११.०० (+४५९.८०%)
Lowest
US$ ५.०० (+१५४.४५%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
US$ १७.००
+७६५.१%
11/17/2026
Scott Henry
Alliance Global Partners
Buy
Maintained
US$ ५.००
+१५४.५%
08/24/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
१.६१ करोड
१.६० करोड
१.८७ करोड
१.९२ करोड
Cost of goods sold
५०.७३ लाख
६७.५८ लाख
६९.४८ लाख
५८.८४ लाख
Cost of revenue
५०.७३ लाख
६७.५८ लाख
६९.४८ लाख
५८.८४ लाख
Research and development expenses
-
-
-
१६.७८ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१.४७ करोड
१.५९ करोड
२.०८ करोड
१.७८ करोड
Operating expense
१.५८ करोड
१.७० करोड
२.१८ करोड
२.०५ करोड
Total operating expenses
२.०९ करोड
२.३८ करोड
२.८७ करोड
२.६४ करोड
Operating income
-४७.८९ लाख
-७७.३९ लाख
-१.०० करोड
-७१.९३ लाख
Other non operating income
५.०० हजार
१५.२८ करोड
१.०७ करोड
-१८.०० हजार
EBT including unusual items
-६२.१३ लाख
१४.२३ करोड
९.२२ लाख
-८३.१० लाख
EBT excluding unusual items
-६१.८८ लाख
१४.२३ करोड
८.४० लाख
-८४.१४ लाख
Income tax expense
-८.१६ लाख
५१.३२ लाख
३.२० लाख
-५६.०० हजार
Effective tax rate
१३.१३%
३.६१%
३४.७१%
०.६७%
Other operating expenses
-
-
-
-
Net income
-३९.३७ लाख
११.०४ करोड
-४.६८ लाख
-५८.४५ लाख
Net profit margin
-२४.४९%
६८८.२०%
-२.५०%
-३०.५१%
Earnings per share
-
-
-
-
Interest and investment income
६.३७ लाख
५.७० लाख
१५.८१ लाख
१२.९५ लाख
Interest expense
-२०.४१ लाख
-३३.६८ लाख
-१४.७६ लाख
-२४.९८ लाख
Net interest expenses
-१४.०४ लाख
-२७.९८ लाख
१.०५ लाख
-१२.०३ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-३६.३२ लाख
-६५.२० लाख
-८९.४३ लाख
-६१.२६ लाख
Gain or loss from assets sale
-
-
-८२.०० हजार
-१.०४ लाख
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू